~~<i id='EACA6EAD3E'><strike id='EACA6EAD3E'><tt id='EACA6EAD3E'><pre id='EACA6EAD3E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

explore

author：entertainment 2025-10-01 23:06:14 - browse：61924

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Poland's lawmakers approve a divisive law on Russian influence

leisure time

entertainment

hotspot

Wikipedia

focus

FTXfounderSamBankman-FriedleavesFederalcourt,Wednesday,July26,2023,inNewYork.(APPhoto/MaryAltaffer)T

WSS

White House drug czar issues call for 'recovery

After decades in use, heart stents finally beat placebo

What is STAT's opinion section for?

Doctors in states that ban abortion can still help patients

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

Type 2 diabetes prevention programs work at large scale: study

knowledge

explore

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

What AstraZeneca

Medical leaders decry Supreme Court decision on affirmative action

UnitedHealth sued over use of algorithm in Medicare Advantage plans

State Dept. review finds Biden bears some blame for Afghanistan failures

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

Moonlake's readout produced a cash windfall. Risks remain

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

After affirmative action ruling, medical educators look to 'holistic review'

Today's health inequities arise from racist U.S. history, say experts

entertainment

Publishing genetic code of viruses could cause disaster

NIH chief: government has fallen behind pharma on clinical trials

White House drug czar issues call for 'recovery

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

hotspot

hotspot

Wikipedia

focus